期刊文献+

急性冠状动脉综合症患者超敏C反应蛋白和血脂检测及临床意义 被引量:2

Detection of High Sensitivity C-Reactive Protein and Lipids with Acute Coronary Syndome and Its Clinical Application
原文传递
导出
摘要 目的:探讨血清超敏C反应蛋白(hs-CRP)和非高密度脂蛋白胆固醇(NHDL-C)在急性冠状动脉综合症(ACS)的临床价值。方法:用Roche/MODULAR P生化分析仪胶乳增强免疫比浊法检测hs-CRP、酶法检测总胆固醇(TC)、甘油三酯(TG)、直接匀相法检测高密度脂蛋白胆固醇(HDL-C),非高密度脂蛋白胆固醇(NHDL-C)计算法(TC-HDL-C)。结果:ACS组血清hs-CRP为(13.40±7.80)mg/L、TC(4.84±1.02)mmol/L、TG(1.57±0.86)mmol/L、HDL-C(1.06±0.31)mmol/L、NHDL-C(3.58±0.92)mmol/L;健康对照组血清hs-CRP为(0.82±0.74)mg/L、TC(4.68±0.81)mmol/L、TG(1.38±0.77)mmol/L、HDL-C(1.42较,hs-CRP、HDL-C、NHDL-C水平差异均有显著性(P<0.01),TC、TG水平差异均无显著性;ACS组hs-CRP水平分别与HDL-C、NHDL-C水平进行相关分析,均无直线相关性(r=0.125,0.134);健康对照组用同样指标进行相关分析,也均无直线相关性(r=0.106,0.113)。结论:血清hs-CRP、HDL-C、NHDL-C水平与ACS事件发生有关,可作为ACS患者诊断、治疗、预后的观察指标。 Objective To investigate the clinical value of serum high-sensitivity C-Reactive Protein(hs-CRP) and non-high-density liporotein cholesterol(NHDL-C) on patients with the acute coronary syndrome(ACS).Methods Serum hs-CRP is measured through partical enhanced immuoturbidimetric method by analysis instrument Roche / MODULAR P;Serum total cholesterol(TC) and triglycerides(TG) is examined by enzyme method;Serum high-density lipoprotein cholesterol(HDLC) is detected by the homogenous method;Serum non-high-density...
作者 李桂彩 曹娟
出处 《湖南师范大学学报(医学版)》 2006年第2期23-25,共3页 Journal of Hunan Normal University(Medical Sciences)
关键词 急性冠状动脉综合症 超敏C反应蛋 血脂 非高密度脂蛋白胆固醇 acute coronary artery syndrome high-sensitivity C-reactive protein lipids non-high-density lipoprotein cholesterol
  • 相关文献

参考文献2

二级参考文献11

  • 1The Joint European Society of Cardiology/American College Cardiology Committee. Myocardial infarction redefined -- A consensus document of the Joint European Society of Cardiology/American College Cardiology Committee for the redefinition of myocardial infarction.J Am Coll Cardial,2000,36:959-969.
  • 2Braunwald E,Antman EM,Beasley JW,et al.ACC/AHA Guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction:Executive summary and recommendations.Circulation,2000,102:1193-1209.
  • 3Braunwald E,Antman EM,Beasley JW,et al.ACC/AHA 2002 Guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. http://www.acc.org/clinical/guidelines/unstable/incorporated/UA_incorporated.
  • 4National Institute of Standards and Technology.Certificate of analysis.Standard reference material 2921-human cardiac troponin complex.Gaithersburg (MD):NIST;2004.
  • 5Panteghini M,Forest JC.Standardization in laboratory medicine:New challenges.Clin Chim Acta,2005,355:1-12.
  • 6Wu AHB,Apple FS,Gibler WB,et al.National Academy of Clinical Biochemistry standards of laboratory practice:Recommendations for the use of cardiac markers in coronary artery diseases.Clin Chem,1999,45:1104-1121.
  • 7Pearson TA,Mensah GA,Alexander RW,et al.Markers of inflammation and cardiovascular disease.AHA and CDC Scientific Statement.Circulation,2003, 107:499-511.
  • 8Morrow DA,Braunwald E.Future of biomarkers in acute coronary syndromes:moving toward amultimarker strategy.Circulation,2003,108:250-252.
  • 9Panteghini M,Apple FS,Christenson RH,et al.IFCC Scientific Division.Committee on Standardization of Markers of Cardiac Damage.Use of biochemical markers in acute coronary syndromes.Clin Chem Lab Med,1999,37:687-893.
  • 10杨振华,潘柏申,许俊堂.中华医学会检验学会文件心肌损伤标志物的应用准则[J].中华检验医学杂志,2002,25(3):185-189. 被引量:401

共引文献133

同被引文献13

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部